| Global analysis of transcript and protein levels across the Plasmodium falciparum life cycle KG Le Roch, JR Johnson, L Florens, Y Zhou, A Santrosyan, M Grainger, ... Genome research 14 (11), 2308-2318, 2004 | 540 | 2004 |
| Directional gene expression and antisense transcripts in sexual and asexual stages of Plasmodium falciparum MJ López-Barragán, J Lemieux, M Quiñones, KC Williamson, ... BMC genomics 12, 1-13, 2011 | 348 | 2011 |
| Plasmodium falciparum transmission stages accumulate in the human bone marrow R Joice, SK Nilsson, J Montgomery, S Dankwa, E Egan, B Morahan, ... Science translational medicine 6 (244), 244re5-244re5, 2014 | 345 | 2014 |
| Malaria transmission‐blocking antigen, Pfs230, mediates human red blood cell binding to exflagellating male parasites and oocyst production S Eksi, B Czesny, GJ Van Gemert, RW Sauerwein, W Eling, ... Molecular microbiology 61 (4), 991-998, 2006 | 182 | 2006 |
| Recombinant Pfs230, a Plasmodium falciparum gametocyte protein, induces antisera that reduce the infectivity of Plasmodium falciparum to mosquitoes KC Williamson, DB Keister, O Muratova, DC Kaslow Molecular and biochemical parasitology 75 (1), 33-42, 1995 | 166 | 1995 |
| Plasmodium falciparum Gametocyte Development 1 (Pfgdv1) and Gametocytogenesis Early Gene Identification and Commitment to Sexual Development S Eksi, BJ Morahan, Y Haile, T Furuya, H Jiang, O Ali, H Xu, K Kiattibutr, ... Public Library of Science 8 (10), e1002964, 2012 | 163 | 2012 |
| Type II fatty acid biosynthesis is essential for Plasmodium falciparum sporozoite development in the midgut of Anopheles mosquitoes BCL van Schaijk, TRS Kumar, MW Vos, A Richman, GJ van Gemert, T Li, ... Eukaryotic cell 13 (5), 550-559, 2014 | 142 | 2014 |
| Molecular and immunological characterization of ADP-ribosylarginine hydrolases. J Moss, SJ Stanley, MS Nightingale, JJ Murtagh Jr, L Monaco, K Mishima, ... Journal of Biological Chemistry 267 (15), 10481-10488, 1992 | 139 | 1992 |
| A high-throughput screen targeting malaria transmission stages opens new avenues for drug development K Buchholz, TA Burke, KC Williamson, RC Wiegand, DF Wirth, M Marti Journal of Infectious Diseases 203 (10), 1445-1453, 2011 | 137 | 2011 |
| Chemical signatures and new drug targets for gametocytocidal drug development W Sun, TQ Tanaka, CT Magle, W Huang, N Southall, R Huang, ... Scientific reports 4 (1), 3743, 2014 | 128 | 2014 |
| Cloning and expression of the gene for Plasmodium falciparum transmission-blocking target antigen, Pfs230. KC Williamson, MD Criscio, DC Kaslow | 127 | 1993 |
| Regulation of sexual commitment and gametocytogenesis in malaria parasites GA Josling, KC Williamson, M Llinás Annual review of microbiology 72, 501-519, 2018 | 126 | 2018 |
| Guanine nucleotide-binding proteins that enhance choleragen ADP-ribosyltransferase activity: nucleotide and deduced amino acid sequence of an ADP-ribosylation factor cDNA. SR Price, M Nightingale, SC Tsai, KC Williamson, R Adamik, HC Chen, ... Proceedings of the National Academy of Sciences 85 (15), 5488-5491, 1988 | 121 | 1988 |
| The Proteasome Inhibitor Epoxomicin Has Potent Plasmodium falciparum Gametocytocidal Activity B Czesny, S Goshu, JL Cook, KC Williamson Antimicrobial agents and chemotherapy 53 (10), 4080-4085, 2009 | 119 | 2009 |
| A malaria gametocytocidal assay using oxidoreduction indicator, alamarBlue TQ Tanaka, KC Williamson Molecular and biochemical parasitology 177 (2), 160-163, 2011 | 115 | 2011 |
| Identification of a subtelomeric gene family expressed during the asexual–sexual stage transition in Plasmodium falciparum S Eksi, Y Haile, T Furuya, L Ma, X Su, KC Williamson Molecular and biochemical parasitology 143 (1), 90-99, 2005 | 108 | 2005 |
| Targeted disruption of Plasmodium falciparum cysteine protease, falcipain 1, reduces oocyst production, not erythrocytic stage growth S Eksi, B Czesny, DC Greenbaum, M Bogyo, KC Williamson Molecular Microbiology 53 (1), 243-250, 2004 | 101 | 2004 |
| Transposon mutagenesis identifies genes essential for Plasmodium falciparum gametocytogenesis H Ikadai, K Shaw Saliba, SM Kanzok, KJ McLean, TQ Tanaka, J Cao, ... Proceedings of the National Academy of Sciences 110 (18), E1676-E1684, 2013 | 97 | 2013 |
| Validation of the proteasome as a therapeutic target in Plasmodium using an epoxyketone inhibitor with parasite-specific toxicity H Li, EL Ponder, M Verdoes, KH Asbjornsdottir, E Deu, LE Edgington, ... Chemistry & biology 19 (12), 1535-1545, 2012 | 94 | 2012 |
| Pfs230: from malaria transmission-blocking vaccine candidate toward function. KC Williamson Parasite immunology 25 (7), 2003 | 92 | 2003 |
